Skip to main content
HR 4833 107th Congress House

Accuracy in Pharmaceutical Advertisements Act

Official title: To amend the Federal Food, Drug, and Cosmetic Act to establish authority for the imposition of civil penalties for direct-to-consumer advertisements that violate such Act, and for other purposes.

Introduced: June 20, 2002 See on congress.gov
Commerce CongressCongressional reporting requirementsConsumer protectionDeceptive advertising
More subjectsShow fewer subjects
Drug advertisingDrug industryDrugsFines (Penalties)HealthLaw
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 3, 2002
Referred to the Subcommittee on Health.
May 23, 2002
Referred to the House Committee on Energy and Commerce.
May 23, 2002
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 3, 2002

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Accuracy in Pharmaceutical Advertisements Act - Amends the Federal Food, Drug, and Cosmetic Act to impose civil penalties for misbranding prescription drugs through a direct-to-consumer advertisement should the person fail to correct or cease such advertisement after receiving written notice from the Secretary of Health and Human Services.

Requires the Secretary, acting through the Commissioner of Food and Drugs, to report to the appropriate congressional committees on the prevalence of such advertisements and other, specified particulars.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 4
All 4 Democratic 3 Independent 1
I
Sanders, Bernard
Vermont · Jun 21, 2002
 D
Norton, Eleanor Holmes
District of Columbia · Jun 20, 2002
 D
DeLauro, Rosa L.
Connecticut · May 23, 2002
 D
Kaptur, Marcy
Ohio · May 23, 2002
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4833: Accuracy in Pharmaceutical Advertisements Act. 107th Congress. Open America. https://openamerica.io/bill/107-HR-4833/
MLA
"H.R. 4833: Accuracy in Pharmaceutical Advertisements Act." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-HR-4833/.
Bluebook (legal)
H.R. 4833, 107th Cong. (2026), https://openamerica.io/bill/107-HR-4833/.
Markdown link
[H.R. 4833: Accuracy in Pharmaceutical Advertisements Act](https://openamerica.io/bill/107-HR-4833/)
Report a problem